Revolution Medicines (RVMD) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Revolution Medicines, as the data feed reports them.

Analysts' mean target, 24 analysts
$274.68
68.8% above the price

The 24 analysts reported by the data feed have a mean price target for Revolution Medicines of $274.68, 68.8% above the $162.69 price (range $179.00–$350.00). 6.38% of the float was sold short as of Oct 30, 2026. Institutions hold 98.1% of the shares and insiders 1.8%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$274.68+68.8% vs price
Analysts
24
Short interest
6.38%of float, Oct 30, 2026
Short ratio
6.78 days
Institutions
98.1%
Insiders
1.83%
Beta
1.43

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

24 analysts covering Revolution Medicines, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $162.69.

Analysts' price targets for Revolution Medicines
Mean price target$274.6868.8% above the price (+68.8%)
Median price target$271.5066.9% above the price (+66.9%)
Highest target$350.00115.1% above the price (+115.1%)
Lowest target$179.0010.0% above the price (+10.0%)
Analysts with a target24

Ratings this month · 24 analysts

Strong buy 5(21%)Buy 18(75%)Hold 1(4%)
Analysts' ratings of Revolution Medicines this month, by rating
RatingAnalystsShare
Strong buy521%
Buy1875%
Hold14%
Sell00%
Strong sell00%

The feed averages these to 1.29 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Revolution Medicines

Ownership of Revolution Medicines
Held by institutions98.1%1,028 institutions; percent of shares outstanding
Held by institutions, of the float99.9%
Held by insiders1.83%percent of shares outstanding
Shares outstanding216.29M
Float186.57Mshares available to trade
Insiders' net purchases, six months−105.21K23 purchases (436.27K shares), 24 sales (541.49K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Revolution Medicines
Shares short13.08Mas of Oct 30, 2026
Percent of float6.38%shares short ÷ float
Percent of shares outstanding6.05%shares short ÷ shares outstanding
Short ratio (days to cover)6.78shares short ÷ average daily volume

Revolution Medicines short interest from FINRA, with its history

Trading figures

Trading figures for Revolution Medicines
Beta1.43movement against the market; 1 moves with it
52-week high$224.31
52-week low$67.86
Average volume, 3 months2.18Mshares a day
Average volume, 10 days3.26Mshares a day

Questions and answers

What is the analysts' price target for Revolution Medicines (RVMD)?

As reported by the data feed, the mean price target of the 24 analysts covering Revolution Medicines is $274.68, 68.8% above the latest price of $162.69. The highest target is $350.00 and the lowest $179.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Revolution Medicines stock?

Of the 24 ratings the data feed reports for the current month, 5 are strong buy, 18 buy, 1 hold, 0 sell and 0 strong sell.

How many Revolution Medicines shares are sold short?

As reported by the data feed, 13.08M shares were sold short, 6.38% of the float as of Oct 30, 2026. At the average daily volume that is 6.78 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Revolution Medicines stock?

As reported by the data feed, institutions hold 98.1% of the shares (1,028 institutions) and insiders 1.8%. There are 216.29M shares outstanding, of which 186.57M are in the float.

How much does Revolution Medicines stock move with the market?

Its beta, as reported by the data feed, is 1.43: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $67.86 and $224.31.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/RVMD/statistics

Underlying data: Yahoo Finance.